vs

Side-by-side financial comparison of Broadway Financial Corp (BYFC) and CRYO CELL INTERNATIONAL INC (CCEL). Click either name above to swap in a different company.

Broadway Financial Corp is the larger business by last-quarter revenue ($9.4M vs $7.8M, roughly 1.2× CRYO CELL INTERNATIONAL INC). Broadway Financial Corp runs the higher net margin — 1934.0% vs -48.7%, a 1982.6% gap on every dollar of revenue. On growth, Broadway Financial Corp posted the faster year-over-year revenue change (10.1% vs -2.3%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-13.0K). Over the past eight quarters, Broadway Financial Corp's revenue compounded faster (9.7% CAGR vs -0.1%).

Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

BYFC vs CCEL — Head-to-Head

Bigger by revenue
BYFC
BYFC
1.2× larger
BYFC
$9.4M
$7.8M
CCEL
Growing faster (revenue YoY)
BYFC
BYFC
+12.3% gap
BYFC
10.1%
-2.3%
CCEL
Higher net margin
BYFC
BYFC
1982.6% more per $
BYFC
1934.0%
-48.7%
CCEL
More free cash flow
CCEL
CCEL
$1.2M more FCF
CCEL
$1.2M
$-13.0K
BYFC
Faster 2-yr revenue CAGR
BYFC
BYFC
Annualised
BYFC
9.7%
-0.1%
CCEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BYFC
BYFC
CCEL
CCEL
Revenue
$9.4M
$7.8M
Net Profit
$1.0M
$-3.8M
Gross Margin
77.9%
Operating Margin
-50.6%
Net Margin
1934.0%
-48.7%
Revenue YoY
10.1%
-2.3%
Net Profit YoY
-21.8%
-105.1%
EPS (diluted)
$0.02
$-0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BYFC
BYFC
CCEL
CCEL
Q4 25
$9.4M
$7.8M
Q3 25
$9.0M
$7.8M
Q2 25
$8.1M
$7.9M
Q1 25
$8.3M
$8.0M
Q4 24
$8.6M
$8.0M
Q3 24
$8.7M
$8.1M
Q2 24
$8.2M
$8.0M
Q1 24
$7.8M
$7.9M
Net Profit
BYFC
BYFC
CCEL
CCEL
Q4 25
$1.0M
$-3.8M
Q3 25
$-23.9M
$749.4K
Q2 25
$752.0K
$355.8K
Q1 25
$-2.7M
$282.9K
Q4 24
$1.3M
$-1.9M
Q3 24
$516.0K
$1.1M
Q2 24
$256.0K
$655.8K
Q1 24
$-154.0K
$556.2K
Gross Margin
BYFC
BYFC
CCEL
CCEL
Q4 25
77.9%
Q3 25
77.0%
Q2 25
76.6%
Q1 25
75.1%
Q4 24
78.4%
Q3 24
73.6%
Q2 24
74.8%
Q1 24
73.7%
Operating Margin
BYFC
BYFC
CCEL
CCEL
Q4 25
-50.6%
Q3 25
-256.2%
24.3%
Q2 25
12.8%
18.8%
Q1 25
-45.3%
13.3%
Q4 24
21.7%
-1.5%
Q3 24
8.5%
17.2%
Q2 24
4.8%
17.3%
Q1 24
-2.9%
10.5%
Net Margin
BYFC
BYFC
CCEL
CCEL
Q4 25
1934.0%
-48.7%
Q3 25
-264.2%
9.6%
Q2 25
9.3%
4.5%
Q1 25
-32.3%
3.5%
Q4 24
15.3%
-23.2%
Q3 24
5.9%
13.0%
Q2 24
3.1%
8.2%
Q1 24
-2.0%
7.1%
EPS (diluted)
BYFC
BYFC
CCEL
CCEL
Q4 25
$0.02
$-0.46
Q3 25
$-2.86
$0.09
Q2 25
$0.00
$0.04
Q1 25
$-0.39
$0.03
Q4 24
$0.07
$-0.23
Q3 24
$-0.03
$0.13
Q2 24
$0.02
$0.08
Q1 24
$-0.02
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BYFC
BYFC
CCEL
CCEL
Cash + ST InvestmentsLiquidity on hand
$10.5M
$3.3M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$262.8M
$-18.6M
Total Assets
$1.3B
$61.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BYFC
BYFC
CCEL
CCEL
Q4 25
$10.5M
$3.3M
Q3 25
$19.7M
$3.2M
Q2 25
$29.5M
$4.4M
Q1 25
$15.8M
$3.5M
Q4 24
$61.4M
$3.5M
Q3 24
$97.1M
$2.1M
Q2 24
$89.8M
$1.5M
Q1 24
$67.1M
$979.6K
Total Debt
BYFC
BYFC
CCEL
CCEL
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
BYFC
BYFC
CCEL
CCEL
Q4 25
$262.8M
$-18.6M
Q3 25
$261.7M
$-14.8M
Q2 25
$284.7M
$-15.6M
Q1 25
$283.6M
$-14.7M
Q4 24
$285.0M
$-13.2M
Q3 24
$286.2M
$-9.6M
Q2 24
$282.1M
$-10.7M
Q1 24
$281.1M
$-10.3M
Total Assets
BYFC
BYFC
CCEL
CCEL
Q4 25
$1.3B
$61.7M
Q3 25
$1.3B
$63.2M
Q2 25
$1.2B
$64.4M
Q1 25
$1.3B
$64.4M
Q4 24
$1.3B
$64.7M
Q3 24
$1.4B
$62.9M
Q2 24
$1.4B
$62.6M
Q1 24
$1.4B
$61.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BYFC
BYFC
CCEL
CCEL
Operating Cash FlowLast quarter
$230.0K
$1.3M
Free Cash FlowOCF − Capex
$-13.0K
$1.2M
FCF MarginFCF / Revenue
-0.1%
15.5%
Capex IntensityCapex / Revenue
2.6%
0.9%
Cash ConversionOCF / Net Profit
0.22×
TTM Free Cash FlowTrailing 4 quarters
$2.3M
$5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BYFC
BYFC
CCEL
CCEL
Q4 25
$230.0K
$1.3M
Q3 25
$3.8M
$2.5M
Q2 25
$3.0M
$707.0K
Q1 25
$-4.3M
$954.1K
Q4 24
$1.4M
$2.2M
Q3 24
$6.1M
$2.4M
Q2 24
$9.8M
$1.8M
Q1 24
$-11.7M
$-356.9K
Free Cash Flow
BYFC
BYFC
CCEL
CCEL
Q4 25
$-13.0K
$1.2M
Q3 25
$3.7M
$2.5M
Q2 25
$3.0M
$644.6K
Q1 25
$-4.4M
$892.0K
Q4 24
$1.3M
$2.1M
Q3 24
$6.1M
$2.3M
Q2 24
$9.7M
$21.5K
Q1 24
$-11.7M
$-814.6K
FCF Margin
BYFC
BYFC
CCEL
CCEL
Q4 25
-0.1%
15.5%
Q3 25
41.1%
31.9%
Q2 25
37.0%
8.1%
Q1 25
-52.4%
11.2%
Q4 24
14.7%
26.8%
Q3 24
69.6%
27.9%
Q2 24
118.9%
0.3%
Q1 24
-149.7%
-10.4%
Capex Intensity
BYFC
BYFC
CCEL
CCEL
Q4 25
2.6%
0.9%
Q3 25
1.2%
0.5%
Q2 25
0.2%
0.8%
Q1 25
0.2%
0.8%
Q4 24
1.6%
0.1%
Q3 24
0.3%
2.3%
Q2 24
0.5%
21.8%
Q1 24
0.7%
5.8%
Cash Conversion
BYFC
BYFC
CCEL
CCEL
Q4 25
0.22×
Q3 25
3.38×
Q2 25
4.00×
1.99×
Q1 25
3.37×
Q4 24
1.06×
Q3 24
11.85×
2.32×
Q2 24
38.21×
2.70×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons